Purchase Order 75F40122P00159
- Not listed
- The Department of Health and Human Services Food and Drug Administration awarded a $918,227.19 firm-fixed-price definitive contract to Life Technologies Corporation, now part of Thermo Fisher Scientific Inc., for the provision of genetic analyzers, warranty, and maintenance services. The contract has an April 26, 2024 completion date and was awarded on April 18, 2019 without the use of a set-aside. Life Technologies Corporation, a leading provider of biomedical research and genetic analysis...
- The U.S. Food and Drug Administration awarded a sole-source purchase order to Life Technologies Corporation for the procurement of a King Fisher Apex96 deep well instrument for DNA lysate preparation. The contract, valued at $66,736.94 on a firm fixed-price basis, was awarded June 25, 2021, with an ultimate completion date of August 29, 2022. The place of performance is Grand Island, New York. This award reflects the FDA's need for specialized genetic analysis instrumentation to support its...
- The U.S. Food and Drug Administration (FDA) awarded a $87,843.87 firm-fixed-price purchase order to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, to provide preventative and corrective maintenance services for 7,500 real-time PCR systems over a 4-year period ending on August 31, 2025. This award was not set aside for any small business program. The original solicitation, FDA_21-223-1236746, was posted on November 10, 2020 with a due date of...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is for the delivery of a genetic analyzer with a 4-year post-warranty maintenance option, with a ceiling value of $80,335.95 and a completion date of September 14, 2025. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools and technologies to government agencies and...
- The U.S. Food and Drug Administration (FDA) awarded a $76,772.10 firm fixed-price purchase order to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for an ABI 7500 Fast Real-Time PCR Instrument. This sole-source award was made under FAR 6.302-1, FAR 13.106(b), and FAR 5.203, as the FDA determined that only Life Technologies could provide the required system. The award does not have a set-aside designation. As a manufacturer of scientific instruments, reagents, and...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, for a MICROSEQ GENETIC ANALYZER. The $323,879.64 award does not have a set-aside designation and was made on August 24, 2017 with a completion date of August 23, 2021. As a division of Thermo Fisher Scientific, Life Technologies serves as a prime contractor across various federal...
- Life Technologies Corporation, doing business as Thermofisher Scientific, has been awarded a delivery order valued at $18.8K by a civilian federal agency in the Northeast Area, with performance in Orono, Maine and an ultimate completion date of September 28, 2024. This firm fixed-price contract, awarded on September 9, 2024 without set-aside designation, provides proprietary DNA extraction kits necessary to support the agency's recently acquired Kingfisher automated DNA extraction machine and...
- The Food and Drug Administration (FDA) awarded a firm fixed-price purchase order valued at $37,145.96 to Life Technologies Corporation (doing business as Thermo Fisher Scientific) on August 15, 2023, for a QuantStudio 7 Flex real-time polymerase chain reaction (qPCR) system with preventative maintenance and unlimited repairs service agreement. The contract covers a base period with two option years, with an ultimate completion date of August 14, 2026. The contract was awarded without set-aside...
- This federal contract award is for REAL TIME PCR ACCESSORIES valued at $20,923.80. The contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to the prime contractor Life Technologies Corporation, doing business as Thermo Fisher Scientific. Life Technologies is a prominent manufacturer of scientific instruments, reagents, and consumables that provides specialized biotechnology products and services to federal agencies. The contract is a firm fixed price purchase order...
- Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc., was awarded a firm fixed-price purchase order valued at $24,459.12 by a civilian federal agency on May 5, 2015, with an ultimate completion date of June 22, 2015. The contract was not set-aside and was performed in Grand Island, New York. As a leading provider of biomedical research and genetic analysis tools, Life Technologies supplied specialized scientific products and related services to support federal agencies'...
Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc., was awarded a $82,231.05 firm fixed-price purchase order by the Food and Drug Administration on August 15, 2022, for an Automated Express Nucleic Acid Extraction System (Part # 4467754). The contract was awarded without set-aside designation and has an ultimate completion date of October 14, 2027. The system will be delivered to the FDA's facility in Grand Island, New York. This award supports the FDA's regulatory testing and public health missions by providing specialized equipment for nucleic acid extraction, a critical capability for molecular diagnostic work, disease surveillance, and laboratory analysis conducted by the agency. Life Technologies has established itself as a trusted supplier of biomedical research and genetic analysis tools to federal agencies, with an extensive portfolio of contracts supporting the National Institutes of Health, Centers for Disease Control and Prevention, Department of Veterans Affairs, and other civilian and defense agencies. The company specializes in providing genetic analysis instruments, sequencing systems, molecular diagnostic reagents, and laboratory equipment maintenance services. This award is consistent with Life Technologies' core business of delivering specialized scientific instrumentation to support federal research and regulatory initiatives, and the company maintains active indefinite delivery vehicles with multiple federal agencies, including a $1.4 million blanket purchase agreement with the Department of Veterans Affairs for pathology and laboratory sequencing reagents.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Automated Nucleic Extraction System | 75F40122Q-1251803 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 1/1 | 3/8/22, 1:25 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $56.3k | 8/14/22 |